Qfin Holdings, an AI-empowered Credit-Tech platform, revealed its unaudited financial results for the fourth quarter and full year 2025, including……
Nth Cycle’s Game-Changing Deal with Trafigura Reshaping Metal Recycling Industry
Nth Cycle, a pioneering metal recycling startup based in Burlington, has inked a momentous deal with the renowned Singapore-based metals……
Nvidia’s H200 Chip Production Resumes Amid U.S.-China Trade Challenges
Nvidia has announced the restart of its manufacturing of the H200 chip, marking a strategic move to navigate the complex……
Rise of Nvidia’s H200 Production in Focus amid Expansion Plans for Chinese Market
Nvidia, a leading technology company, has revealed plans to boost production of its H200 chips targeting the Chinese market. The……
Indian Government Allows ESOPs and Investment for NRIs in China, Nepal, and Hong Kong
Indian government’s recent notification, Press Note 2 (PN2), has paved the way for Indian companies to offer stock options to……
China’s Crackdown on Path to Hong Kong IPOs Sends Shockwaves in Market
Recent reports have surfaced indicating that Beijing is imposing restrictions on Chinese companies incorporated overseas from pursuing initial public offerings……
China-U.S. Chip Relations: Nvidia Plans Relaunch of H200 Manufacturing in China
Nvidia’s CEO, Jensen Huang, announced plans to revive manufacturing for H200 China chips during a high-profile press event. Huang emphasized……
China’s Aircraft Carrier Disproves Deployment Claim Near Taiwan
Satellite imagery confirms that China’s newest aircraft carrier, the Fujian, remains docked at the Qingdao naval base, contradicting recent social…
China’s Aircraft Carrier Disproves Deployment Claim Near Taiwan comes via ChinaTechNews.com.
…
China’s Aircraft Carrier Disproves Deployment Claim Near Taiwan
Satellite imagery confirms that China’s newest aircraft carrier, the Fujian, remains docked at the Qingdao naval base, contradicting recent social…
China’s Aircraft Carrier Disproves Deployment Claim Near Taiwan comes via ChinaTechNews.com.
…
Alebund Pharmaceuticals and R1 Therapeutics to Collaborate on AP306 Treatment for Hyperphosphatemia
Alebund Pharmaceuticals has announced a collaboration and license agreement with R1 Therapeutics for the first-in-class pan-phosphate inhibitor, AP306. The agreement……
-
-
Recent Updates
- Qfin Holdings Posts Impressive Financial Results for Q4 and Full Year 2025
- Nth Cycle’s Game-Changing Deal with Trafigura Reshaping Metal Recycling Industry
- Nvidia’s H200 Chip Production Resumes Amid U.S.-China Trade Challenges
- Rise of Nvidia’s H200 Production in Focus amid Expansion Plans for Chinese Market
- Indian Government Allows ESOPs and Investment for NRIs in China, Nepal, and Hong Kong
- China’s Crackdown on Path to Hong Kong IPOs Sends Shockwaves in Market
- China-U.S. Chip Relations: Nvidia Plans Relaunch of H200 Manufacturing in China
- China’s Aircraft Carrier Disproves Deployment Claim Near Taiwan
- China’s Aircraft Carrier Disproves Deployment Claim Near Taiwan
- Alebund Pharmaceuticals and R1 Therapeutics to Collaborate on AP306 Treatment for Hyperphosphatemia
Blogroll